Literature DB >> 1516946

Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.

S Kim1, M Tokuyama, M Hosoi, K Yamamoto.   

Abstract

The plasma and adrenal renin-angiotensin system in stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar-Kyoto (WKY) rats were examined in animals at 5, 11, 18, and 25 weeks of age. Plasma active renin was significantly increased in 18- and 25-week-old SHRSP with impaired renal function, whereas there was no difference in the plasma prorenin level or renal renin content between the two strains at all ages examined. Thus, the rate of activation of prorenin seems to be enhanced in the kidney of SHRSP with malignant hypertension. Adrenal renin contents were severalfold higher in SHRSP than WKY rats at all ages. However, adrenal angiotensin peptides were not increased in SHRSP aged 5 and 11 weeks. In 18-week-old SHRSP, adrenal angiotensin II (Ang II) and III (Ang III) levels were fourfold and 1.8-fold higher, respectively, than in WKY rats, accompanied by 1.5-fold higher plasma aldosterone. Increased adrenal angiotensin and plasma aldosterone were also found in 25-week-old SHRSP. Zonal distribution studies indicated that the elevated Ang II and III in SHRSP were derived mainly from the capsular tissue (the zona glomerulosa). To examine the contribution of circulating angiotensin to the adrenal angiotensin content, effects of bilateral nephrectomy on adrenal angiotensin and renin were examined in 18-week-old rats. At 24 hours after nephrectomy, plasma angiotensin, prorenin, and active renin were decreased to almost negligible concentrations. Conversely, in both adrenal capsular and decapsular tissues of SHRSP and WKY rats, neither angiotensin nor renin was significantly decreased after nephrectomy. These results suggest that the increase in adrenal capsular Ang II contents in SHRSP may be partly due to an enhanced local production of Ang II.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1516946     DOI: 10.1161/01.hyp.20.3.280

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Renin knockout rat: control of adrenal aldosterone and corticosterone synthesis in vitro and adrenal gene expression.

Authors:  Hershel Raff; Ashley Gehrand; Eric D Bruder; Matthew J Hoffman; William C Engeland; Carol Moreno
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

2.  Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.

Authors:  M Miyazaki; H Sakonjo; S Takai
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.

Authors:  Laura C Chambers; Janice M Diaz-Otero; Courtney L Fisher; William F Jackson; Anne M Dorrance
Journal:  J Hypertens       Date:  2022-09-01       Impact factor: 4.776

4.  Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats.

Authors:  Erica C Henning; Steven Warach; Maria Spatz
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

5.  Comparative effect of bisoprolol and losartan in the treatment of essential hypertension.

Authors:  Goran Keković; Branislav Milovanović; Dragomir Davidović; Dejan Raković; Milka Culić
Journal:  J Res Med Sci       Date:  2012-11       Impact factor: 1.852

6.  Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats.

Authors:  Sheon Mary; Philipp Boder; Giacomo Rossitto; Lesley Graham; Kayley Scott; Arun Flynn; David Kipgen; Delyth Graham; Christian Delles
Journal:  Clin Sci (Lond)       Date:  2021-12-22       Impact factor: 6.124

Review 7.  Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism.

Authors:  Xiao Lin; Muhammad Hasnain Ehsan Ullah; Xiong Wu; Feng Xu; Su-Kang Shan; Li-Min Lei; Ling-Qing Yuan; Jun Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-02

8.  Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP.

Authors:  Daniel Pirici; Luiza Stanaszek; Cornelia Garz; Solveig Niklass; Hans-Jochen Heinze; Thomas Kalinski; Johannes Attems; Stefanie Schreiber
Journal:  Brain Pathol       Date:  2016-05-30       Impact factor: 6.508

Review 9.  Utilizing proteomics to understand and define hypertension: where are we and where do we go?

Authors:  Christian Delles; Emma Carrick; Delyth Graham; Stuart A Nicklin
Journal:  Expert Rev Proteomics       Date:  2018-07-12       Impact factor: 3.940

10.  Impact of angiotensin-converting enzyme inhibition on platelet tissue factor expression in stroke-prone rats.

Authors:  Marta Brambilla; Paolo Gelosa; Laura Rossetti; Laura Castiglioni; Chiara Zara; Paola Canzano; Elena Tremoli; Luigi Sironi; Marina Camera
Journal:  J Hypertens       Date:  2018-06       Impact factor: 4.844

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.